Orchestra BioMed Holdings, Inc.
OBIO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001814114
In the last 90 days, Orchestra BioMed Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 77 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Orchestra BioMed Holdings, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 2 filings
- 2 insiders, $58.6K in total
- Open-market sells
- 3 filings
- 1 insider, $199.5K in total
- Insiders trading
- 2
- Net value
- −$140.9K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Orchestra BioMed Holdings, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Hochman David P | See Remarks | 432,916Indirect | Sep 11, 2026 | 11 |
| Sherman Darren | See Remarks | 1,134,402 | Sep 2, 2026 | 11 |
| Taylor Andrew Lawrence | Chief Financial Officer | 589,989 | Aug 28, 2026 | 7 |
| Aiello Joshua | Principal Accounting Officer | 18,441 | Aug 28, 2026 | 4 |
| Pacitti David | Director | 54,750 | Aug 14, 2026 | 2 |
| Fain Eric S | Director | 99,630Indirect | Aug 14, 2026 | 3 |
| Mack John Prosper | Director | 66,544 | Aug 14, 2026 | 2 |
| Cleary Chris | Director | 29,153 | Aug 14, 2026 | 3 |
| Aryeh Jason | Director | 118,118 | Jun 25, 2026 | 3 |
| Yanchik Connealy Pamela | Director | 66,038 | Jun 25, 2026 | 1 |
| RTW Investments, LP | 10% Owner | 9,556,063Indirect | Apr 29, 2026 | 1 |
| Wong Roderick | 10% Owner | 9,556,063Indirect | Apr 29, 2026 | 1 |
| Edelman Joseph | 10% Owner | 5,292,556Indirect | Aug 5, 2025 | 0 |
| Perceptive Advisors LLC | 10% Owner | 5,292,556Indirect | Aug 5, 2025 | 0 |
| Perceptive Life Sciences Master Fund Ltd | 10% Owner | 5,292,556Indirect | Aug 5, 2025 | 0 |
| HSAC 2 Holdings, LLC | 10% Owner | 1,705,705 | Aug 7, 2024 | 0 |
| Rose Eric A MD | Director | 7,544 | Jun 21, 2024 | 0 |
| Little William Reed | See Remarks | 307,859 | Jun 3, 2024 | 0 |
| Mika Yuval | See Remarks | 158,905 | May 10, 2024 | 0 |
| Papandreou George | See Remarks | 42,000 | May 10, 2024 | 0 |
| Smith Geoffrey Wade | Director | 20,913 | Jul 24, 2023 | 0 |
| Kaswan Michael | Chief Financial Officer | 133,545 | May 19, 2023 | 0 |
| Medtronic plc | 10% Owner | 4,999,423Indirect | Feb 1, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 (view filing)8:15 AM ET | Sep 3 | 5 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +10.0K | $4.79 | +$47.9K | +0.9%1.07M after | |
| Sep 2, 2026 (view filing)4:15 PM ET | Sep 1 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −15.0K | $4.94 | −$74.1K | −1.3%1.13M after | 10b5-1 |
| Aug 28, 2026 (view filing)4:15 PM ET | Aug 26 | 2 days | Sherman DarrenSee Remarks | PPurchase | +2.00K | $5.33 | +$10.7K | New position2.00K after | |
| Aug 4, 2026 (view filing)4:49 PM ET | Aug 3 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share | −15.0K | $4.09 | −$61.4K | −1.3%1.15M after | 10b5-1 |
| Jul 2, 2026 (view filing)4:15 PM ET | Jul 1 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share | −15.0K | $4.27 | −$64.0K | −1.3%1.17M after | 10b5-1 |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +5.00K | $3.83 | +$19.1K | +0.5%1.06M after | |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share | −15.0K | $3.87 | −$58.0K | −1.3%1.18M after | 10b5-1 |
| May 20, 2026 (view filing) | May 18 | 2 days | Aryeh JasonDirector | PPurchaseCommon Stock, par value $0.0001 per share | +665 | $3.75 | +$2.49K | +0.6%118.1K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Aryeh JasonDirector | PPurchaseCommon Stock, par value $0.0001 per share | +8.97K | $3.90 | +$35.0K | +8.3%117.5K after | |
| May 19, 2026 (view filing) | May 15 | 4 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +5.00K | $3.77 | +$18.9K | +0.5%1.06M after | |
| May 18, 2026 (view filing) | May 14 | 4 days | Fain Eric SDirector | PPurchaseCommon Stock, par value $0.0001 per share | +20.0K | $4.13 | +$82.6K | +27.9%91.7K after | |
| Apr 29, 2026 (view filing)5:36 PM ET | Apr 27 | 2 days | RTW Investments, LP and 1 other10% Owner | SSale | −32 | $4.13 | −$132.16 | 0.0%9.56M after | |
| Mar 16, 2026 (view filing) | Mar 13 | 3 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +10.0K | $4.29 | +$42.9K | +0.9%1.09M after | |
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +5.00K | $4.07 | +$20.4K | +0.8%612.8K after | |
| Sep 19, 2025 (view filing) | Sep 19 | Same day | Aryeh JasonDirector | PPurchaseCommon Stock, par value $0.0001 per share | +1.00K | $2.45 | +$2.45K | +0.9%108.5K after | |
| Aug 25, 2025 (view filing) | Aug 25 | Same day | Fain Eric SDirector | PPurchaseCommon Stock, par value $0.0001 per share | +5.76K | $2.61 | +$15.0K | +8.7%71.7K after | |
| Aug 25, 2025 (view filing) | Aug 25 | Same day | Sherman DarrenSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share | +3.00K | $2.62 | +$7.86K | +0.3%926.8K after | |
| Aug 25, 2025 (view filing) | Aug 21 | 4 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +6.00K | $2.49 | +$14.9K | +0.9%651.5K after | |
| Aug 25, 2025 (view filing) | Aug 25 | Same day | Taylor Andrew LawrenceChief Financial Officer | PPurchaseCommon Stock, par value $0.0001 per share | +2.00K | $2.55 | +$5.10K | +0.4%482.8K after | |
| Aug 6, 2025 (view filing)4:28 PM ET | Aug 4 | 2 days | RTW Investments, LP and 1 other10% Owner | PPurchase | +3.64M | $2.75 | +$10.0M | –3.64M after | Derivative |
| Aug 5, 2025 (view filing)10:46 AM ET | Aug 1 | 4 days | Edelman Joseph and 2 others10% Owner | PPurchase | +700.0K | $2.75 | +$1.93M | +15.2%5.29M after | |
| Aug 5, 2025 (view filing)10:46 AM ET | Aug 1 | 4 days | Edelman Joseph and 2 others10% Owner | PPurchase | +1.50M | $2.75 | +$4.12M | –1.50M after | Derivative |
| Aug 4, 2025 (view filing) | Aug 4 | Same day | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +20.0K | $2.75 | +$55.0K | +6.1%349.3K after | |
| Jun 27, 2025 (view filing) | Jun 26 | 1 day | Fain Eric SDirector | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −2.68K | $3.05 | −$8.18K | −5.0%50.9K after | |
| May 1, 2025 (view filing)8:18 AM ET | Apr 30 | 1 day | RTW Investments, LP and 1 other10% Owner | PPurchase | +49.9K | $2.99 | +$149.2K | +0.6%8.31M after | |
| Apr 29, 2025 (view filing)5:16 PM ET | Apr 29 | Same day | RTW Investments, LP and 1 other10% Owner | PPurchase | +50.0K | $2.53 | +$126.5K | +0.6%8.26M after | |
| Dec 26, 2024 (view filing) | Dec 23 | 3 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +4.00K | $4.66 | +$18.6K | +0.7%579.5K after | |
| Dec 20, 2024 (view filing) | Dec 19 | 1 day | Taylor Andrew LawrenceChief Financial Officer | PPurchaseCommon Stock, par value $0.0001 per share | +1.00K | $4.83 | +$4.83K | +0.3%345.0K after | |
| Dec 19, 2024 (view filing) | Dec 18 | 1 day | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +5.00K | $4.91 | +$24.6K | +0.9%575.5K after | |
| Sep 26, 2024 (view filing) | Sep 24 | 2 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +2.50K | $4.91 | +$12.3K | +0.4%570.5K after | |
| Sep 26, 2024 (view filing) | Sep 25 | 1 day | Hochman David PSee Remarks | PPurchase | +7.50K | $4.75 | +$35.6K | New position2.00K after | 4 lots |
| Sep 10, 2024 (view filing) | Sep 9 | 1 day | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −6.80K | $5.48 | −$37.3K | −0.9%772.7K after | |
| Sep 10, 2024 (view filing) | Sep 10 | Same day | Sherman DarrenSee Remarks | SSale | −6.90K | $5.31 | −$36.7K | −0.9%765.8K after | |
| Sep 10, 2024 (view filing) | Sep 6 | 4 days | Fain Eric SDirector | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −2.00K | $5.64 | −$11.3K | −4.3%44.8K after | |
| Sep 10, 2024 (view filing) | Sep 9-10 | 1 day | Fain Eric SDirector | SSale | −3.60K | $5.39 | −$19.4K | −8.0%41.2K after | 2 lots |
| Sep 6, 2024 (view filing) | Sep 4 | 2 days | Sherman DarrenSee Remarks | SSaleCommon Stock, par value $0.0001 per share ("Common Stock") | −6.84K | $6.10 | −$41.7K | −0.9%793.3K after | |
| Sep 6, 2024 (view filing) | Sep 5-6 | 1 day | Sherman DarrenSee Remarks | SSale | −13.8K | $5.75 | −$79.2K | −1.7%779.5K after | 2 lots |
| Aug 15, 2024 (view filing) | Aug 14 | 1 day | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +2.50K | $5.84 | +$14.6K | +0.4%568.0K after | |
| Jun 26, 2024 (view filing) | Jun 25 | 1 day | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +1.00K | $6.95 | +$6.95K | +0.3%333.5K after | |
| Jun 3, 2024 (view filing) | May 30 | 4 days | Little William ReedSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +4.00K | $7.00 | +$28.0K | +1.3%307.9K after | |
| May 21, 2024 (view filing) | May 16 | 5 days | Hochman David PSee Remarks | PPurchaseCommon Stock, par value $0.0001 per share ("Common Stock") | +2.00K | $4.75 | +$9.50K | +0.6%329.5K after | Amended |
| May 21, 2024 (view filing) | May 17 | 4 days | Hochman David PSee Remarks | PPurchase | +3.00K | $5.15 | +$15.4K | +0.9%332.5K after | Amended |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Medtronic plc10% Owner | PPurchase | +6.83K | $9.28 | +$63.4K | +0.1%5.00M after | |
| Jan 26, 2023 (view filing) | Jan 24 | 2 days | Wong RoderickChief Executive Officer | PPurchase | +1.81M | $10.00 | +$18.1M | +180.9%2.81M after | |
| Jul 25, 2022 (view filing) | Jul 22 | 3 days | Wong RoderickChief Executive Officer | PPurchase | +1.00M | $10.01 | +$10.0M | New position1.00M after |